Insulin is a potent adipogenic hormone that triggers an induction of a series of transcription factors governing differentiation of pre-adipocytes into mature adipocytes.
INTRODUCTION:
White adipose tissue (WAT) is the major site of the regulated energy store and release in response to hormones and nutrients at times of nutritional abundance and deprivation. WAT mass is a reflection of the number of adipocytes and their volume.
The latter is dependent upon the amount of fat stored in the individual fat cell, while the former increases as a result of new adipocyte differentiation from pre-adipocytes.
Because mature adipocytes do not undergo cell division and lose their ability to propagate, any increase in their number reflects the process of differentiation of preadipocytes into mature adipocytes (1, 2) . This process of differentiation of pre-adipocytes into adipocytes culminates in increased transcription of certain genes and expression of specific proteins such as the insulin sensitive glucose transporter GLUT-4 (3), fatty acid synthase (FAS) (4) , and glycerol-2-phosphate dehydrogenase (5) . Understanding the process of adipocyte differentiation becomes vitally important for unraveling the pathogenesis of obesity that is characterized by increased WAT mass.
Several excellent reviews have summarized the current understanding of the mechanism of adipocyte differentiation (6) (7) (8) (9) (10) . These reviews emphasize that during adipocyte differentiation, regardless of the nature of the triggering event, a series of transcription factors CCAAT/enhancer binding protein [C/EBP]β, ´, and α, PPARγ, etc) is induced in a specific sequence (6) (7) (8) (9) (10) . In in vitro studies, a combination of dexamethasone, isobutylmethylxanthine (IBMX), and insulin is commonly used to induce this sequence of events. Understanding the role of insulin, the most potent among the three inducers, appears to be of special importance, because of the potential influence of in vivo hyperinsulinemia on the development of obesity. Although insulin within its physiologic range has been shown to induce lipogenesis and adipocyte differentiation (11, 12) , the mechanism of its action on adipogenesis is incompletely understood.
From the point of view of insulin signaling, the presence of the insulin receptor appears to be required for adipocyte differentiation (13, 14) . Furthermore, inhibition of phosphatidylinositol 3-kinase (PI 3-kinase) has been shown to block insulin-induced differentiation of 3T3-L1 pre-adipocytes (15) (16) . Because a variety of other agents also activate PI 3-kinase and its downstream targets without any effect on adipocyte differentiation, it is plausible that insulin engages another branch(es) of its signaling pathways into the mechanism of its action on adipogenesis.
We have recently determined that prenylation of Ras and Rho proteins is regulated by insulin (17, 18) . We further demonstrated that prenylation of these proteins is significantly augmented by ambient hyperinsulinemia either present in insulin resistant humans and animals or induced experimentally in controls (19, 20) . Insulin appears to promote the phosphorylation and activation of farnesyltransferase (FTase) and geranylgeranyltransferase I (GGTase I) by a mechanism independent of PI 3-kinase (21, 22) . Availability of prenylated p21 Ras is required for the activation of MAP kinase (23, 24) . The latter has been shown to phosphorylate and activate cyclic AMP response element binding (CREB) protein that is critically important for adipogenesis (25) .
Conceivably, insulin's ability to promote prenylation of the Ras family of GTPases may constitute an additional mechanism of the insulin effect on adipogenesis. In this study we examined whether inhibition of prenylation of p21 Ras and Rho-A can affect insulin-induced 3T3-1adipocyte differentiation.
Experimental Procedures
Materials: All standard chemicals were from Sigma (St. Louis, MO) and anti-Ras monoclonal antibody was from Transduction Laboratories (Lexington, KY). Antibodies to PPARγ2, GLUT-4, leptin, and Rho-A antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-active MAP kinase antibody, CREB and phospho-CREB specific antibodies were from Cell Signaling (Beverly, MA), and antifatty acid synthetase (FAS) antibody was purchased from Pharmingen (San Diego, CA).
All supplies and reagents for SDS-PAGE were from Bio-Rad (Hercules, CA), and Cell Culture: 3T3-L1 fibroblasts were grown to confluence in fibroblast growth medium (Dulbecco's modified Eagle's medium containing 5.5 mM glucose, 10% fetal calf serum (FCS), 50µg/ml gentamicin, 0.5 mM glutamine, and 0.5 µg/ml fungizone).
Differentiation was initiated by addition of medium containing 10% FCS, 1 mM glutamine, 500 µM isobutylmethylxanthine (IBMX) (or 3mM Bt2cAMP), 1µM dexamethasone, and 1 µg/ml insulin. After two days, cells were transferred to adipocyte growth medium containing 25 mM glucose, 50µg/ml gentamicin, 0.5 mM glutamine, and 0.5 µg/ml fungizone, 10% FCS, 1 mM glutamine, and 1 µg/ml insulin and re-fed every two days. Differentiation of fibroblasts into mature adipocytes was confirmed by Oil Red O staining (27) . FTase inhibitor (FTI) and GGTase I inhibitor (GGTI) were used in concentrations of 1 ¼M and 3 ¼M, respectively.
Transfection procedures: Plates of 3T3-L1 fibroblasts were grown to 70-80% confluency and transfected with the indicated plasmids with Superfect Reagent (Qiagen, Valencia, CA) according to the manufacturer's recommendations. Cells stably transfected with the plasmid pVgRXR were selected in conventional medium containing 500 ug/ml Zeocin, and cells stably transfected with pIND-VP16-CREB, pIND-CREB-DIEDML or pIND-LacZ) plasmids were selected in medium containing 500 ug/ml Geneticin. Large, rapidly growing, well-separated colonies were isolated 10 to 12 days after selection was begun with either antibiotic. Isolated clones were passaged in low glucose DMEM containing 10% FCS, 1 mM L-glutamine, and 500 ug/ml each of Zeocin and Geneticin. VP16-CREB, CREB-DIEDML or LacZ expression was induced through the addition of 5 µM Ponasterone A to the growth medium as indicated in the figure legends. Differentiation of 3T3-L1 preadipocytes to mature adipocytes was followed by observing the accumulation of triacylglycerol in Oil Red O staining vesicles and by the appearance of adipocyte markers: PPARγ2, GLUT-4, fatty acid synthase, and leptin. Differentiation assays were performed on cells growing on 8 chamber microscope slides. Ten days following the initiation of differentiation, the cells were stained with Oil Red O as previously described (25, 27) , and counterstained with Hematoxylin to visualize cell morphology. Cells were observed by brightfield microscopy and representative fields were photographed with Kodak 200 film.
Alternately, cells growing on multiwell slides were lysed directly in Laemmli SDS gel loading buffer, and the lysates subjected to Western blot analysis for marker protein expression.
Ecdysone-Inducible VP16-CREB and CREB-DIEDML Expression System: The
Ecdysone-Inducible Expression System was employed to prepare stably transfected 3T3-L1cells in which we could induce the expression of VP16-CREB and CREB-DIEDML as decsribed previously (25) .
Western blot analysis: After correcting for protein concentrations, lysates from 3T3-L1
fibroblasts and adipocytes treated as described in the figure legends were prepared in Laemmli SDS loading buffer, resolved on 10% polyacrylamide-SDS gels (for PPARγ2, FAS, GLUT-4, and leptin) or 12% acrylamide gels (for C/EBPα, C/EBPβ, CREB, phospho-CREB, ERK (MAP), and phospho-ERK), and transferred to nitrocellulose.
The nitrocellulose blots were blocked with phosphate buffered saline containing 5% dry milk and 0.1% Tween 20, and then treated with antibodies that recognize C/EBPα, C/EBPβ, CREB, phospho-CREB, ERK (MAP), phospho-ERK, PPARγ2, FAS, GLUT-4, or leptin. The blots were washed and subsequently treated with goat anti-rabbit IgG conjugated to alkaline phosphatase. After the blots were washed, specific immune complexes for PPARγ2, FAS, GLUT-4, or leptin were visualized with bromo-chloroindoyl-phosphate and nitro blue tetrazolium, while the remaining proteins were detected by ECL chemiluminescence.
Statistical analysis: All statistics were analyzed by Student's "t" test, with a P value of < 0.5 considered significant.
Results.
In the initial set of experiments, we examined the effect of the inhibitors of FTase (1 ¼M) and GGTase I (3 ¼M) on the insulin-induced differentiation of 3T3-L1 fibroblasts. The inhibitors were added either individually or together, at the time of the induction and kept in the media throughout the differentiation period (days 1-10). The presence of either inhibitor alone or in a combination in the differentiation mixture completely blocked differentiation of these cells into mature adipocytes (Fig. 1) .
We then examined the effect of the prenylation inhibitors on the expression of the transcription proteins participating in the pre-adipocyte differentiation process. In control cells, C/EBP² was expressed on day 2 and C/EBP± appeared on day 4. Both inhibitors, FTI and GGTI, blocked the expression of C/EBPβ and C/EBP± (Fig.2) , thus indicating that farnesylation and geranylgeranylation are necessary for the induction of C/EBP² and C/EBP± expression.
Because insulin stimulates prenylation of p21 Ras and Rho-A ( 17, 18, 28, 29) , a process that is required for subsequent activation of these GTPases and their downstream targets (30), we examined the effect of inhibitors of FTase and GGTase I on the ability of insulin to activate MAP kinase and CREB, two downstream signaling intermediates.
In the absence of either FTI or GGTI, insulin induced the phosphorylation of both MAP kinase (Fig. 3A & B , upper panels) and CREB (Fig 4A &B, upper panels) . The effect of insulin was clearly evident when the results were expressed as ratios of phospho-proteins to the total amount of MAP kinase and CREB (Fig. 3 and 4, lower panels) . The inhibitor of FTase significantly decreased the ability of insulin to activate MAP kinase (Fig. 3A) and to phosphorylate CREB (Fig. 4A) , without affecting the amounts of either MAP kinase or CREB protein (Fig. 3A and 4A, middle panels) . In contrast, inhibition of (Fig. 5) . As expected, differentiation mixture induced PPAR³2, FAS, leptin, and GLUT-4 proteins, and both constructs of the constitutively active CREB mimicked this effect in the absence of the differentiation mixture (Fig 6) .
Moreover, induction of either of the two constructs rescued adipocyte differentiation from the inhibitory influence of prenyltransferase inhibitors (Fig. 7) . Induction of constitutively active CREB with ponasterone A stimulated expression of PPAR³2, leptin, and FAS in cells treated with FTI and/or GGTI (Fig 8) .
Discussion:
Obesity has emerged as a major health care concern in the United States and many other countries. Weight gain and obesity occur when energy intake exceeds energy expenditure and excess energy is deposited in adipocytes. At the cellular level, obesity is characterized by both adipocyte hypertrophy and increased number of adipocytes (31, 32) .
New adipocytes largely arise in the process of differentiation of pre-adipocytes. Over the past decade, there has been an explosion of knowledge about intrinsic regulatory mechanisms determining adipocyte differentiation (reviewed in 6-10). It has been determined that adipocyte differentiation is a highly regulated process that involves sequential activation of several transcription factors, such as C/EBP², C/EBP±, and PPAR³, culminating in the removal of adipocytes from the cell cycle and induction of highly specific proteins, such as GLUT-4, FAS and others (1-10).
Nutritional influence, as well as the presence of insulin and glucocorticosteroids appears to be among the most important triggers of the differentiation process. Insulin, however, occupies a special place among various factors regulating white adipose tissue mass. Fasting and/or glucose-induced hyperinsulinemia are characteristic features of obesity. Whether or not hyperinsulinemia can participate in further augmentation of WAT mass remains to be defined further. Clearly, hyperinsulinemia, induced either by administration of exogenous insulin (intensive therapy with insulin) or increases in production of endogenous insulin (insulinoma), is associated with significant weight gain.
It is plausible, but not yet proven, that endogenous hyperinsulinemia elicited by excessive food intake can promote adipogenesis, significantly increases WAT mass, and cause obesity with secondary metabolic resistance to insulin. However, it is obvious that insulin has a strong anti-lipolytic action, stimulates lipogenesis, and triggers and promotes new adipocyte differentiation in vitro.
Even though recent studies have demonstrated a requirement for the insulin receptor and activation of PI 3-kinase and Akt in the process of adipogenesis (13-16) Recently, the phosphorylation of CREB has been found to be necessary and sufficient to induce adipogenesis in 3T3-L1 fibroblasts (25) . Inducible expression of a constitutively active VP16-CREB alone was sufficient to initiate adipogenesis as determined by triacylglycerol storage, cell morphology, and the expression of adipocyte marker genes, PPAR³ and FAS (25) . Alternatively, expression of a non-DNA binding dominant negative mutant of CREB, KCREB, blocked adipocyte differentiation in cells treated with insulin, dexamethasone, and IBMX (25). Finally, recombinant or endogenous CREB in pre-adipocyte nuclear extracts was shown to bind to putative CRE sequences in the promoters of several adipocyte-specific genes (25) , further supporting the role of CREB in adipogenesis.
Because insulin is known to promote the phosphorylation of MAP kinase and CREB (33, 34) , and because its effect was blocked by an inhibitor of FTase, we suggest that the connection between the insulin signaling cascade and the intrinsic cascade of adipocyte differentiation occurs via the insulin-induced and MAP-kinase-mediated phosphorylation of CREB, downstream of farnesylated Ras (Fig 9) . Shc, via its SH2 domain, and MAP kinase mediate insulin's effect on FTase (21, 22) . FTase, in turn, farnesylates additional molecules of p21 Ras and increases its availability for subsequent stimulation. This leads to the phosphorylation and activation of MAP kinase and CREB, with the latter connecting insulin signaling with the intrinsic cascade of adipogenesis.
This pathway does not negate or minimize the importance of the possible parallel insulin signaling via PI 3-kinase and Akt. In fact, our own studies (not shown), in concert with reports from other laboratories (15, 16) , demonstrate that inhibition of PI 3-kinase with wortmannin blocked adipocyte differentiation. Furthermore, insulin has been also shown to exert a post-transcriptional control of adipocyte differentiation through an activation of PI 3-kinase (35) that might complement its effect via prenylation. Our present data outline the importance of prenylation and the role of CREB in this process.
The role of geranylgeranylation of Rho-A in the process of adipocyte differentiation is not understood. Clearly, an inhibitor of GGTase I prevented normal insulin-induced differentiation of adipocytes (Fig 1 & 5) . Inhibition of GGTase I had no effect on either the phosphorylation of MAP kinase or CREB (Fig. 3 & 4) , indicating that it arrests adipogenesis at a different step that is independent of CREB signaling and possibly downstream of CREB. However, induction of the constitutively active CREB still rescued the cells from an inhibitory influence of GGTI (Fig. 7) , suggesting that the CREB-and Rho-A-dependent steps are independent of one another and the CREB pathway can overcome inhibition induced by blocked geranylgeranylation. Further studies are needed to determine the role of Rho-A in this process.
Interesting studies comparing insulin with PDGF (36,37) have found that even though both hormones activate PI 3-kinase, PDGF failed to promote adipocyte differentiation. In our previous studies, we observed that PDGF also failed to stimulate the prenylation process (18) . If both PI 3-kinase-and prenylation-dependent pathways are indeed needed for physiological activation of adipogenesis, it becomes clear why insulin and not PDGF stimulates this process. Previous data from our laboratory have demonstrated that only insulin, and not PDGF, IGF-1 or EGF, augments the process of prenylation (18, 28, 29) . Only insulin promotes the phosphorylation of the ±-subunit of the FTase and GGTase I and increases the activity of these enzymes. The effect of insulin appears to involve activation of the MAP kinase (21) and an additional signal involving the Shc SH2 domain (22) (Fig 9) .
In summary, the present observations outline the role of prenylation in the process of the insulin-induced adipogenesis. The current findings also suggest that both the PI 3-kinase and the prenylation pathways are physiologically important to promote adipogenesis, and that insulin, a potent activator of both pathways, is a major regulator of adipocyte differentiation. Inhibition of prenylation with either specific inhibitors or statins (38, 39) may attenuate the magnitude of insulin-induced adipocyte differentiation. 
